206 related articles for article (PubMed ID: 31578370)
41. IRAK4 in TLR/IL-1R signaling: possible clinical applications.
Li X
Eur J Immunol; 2008 Mar; 38(3):614-8. PubMed ID: 18286571
[TBL] [Abstract][Full Text] [Related]
42. Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria.
Mockenhaupt FP; Cramer JP; Hamann L; Stegemann MS; Eckert J; Oh NR; Otchwemah RN; Dietz E; Ehrhardt S; Schröder NW; Bienzle U; Schumann RR
J Commun Dis; 2006 Mar; 38(3):230-45. PubMed ID: 17373355
[TBL] [Abstract][Full Text] [Related]
43. Toll-like receptor polymorphisms and susceptibility to human disease.
Misch EA; Hawn TR
Clin Sci (Lond); 2008 Mar; 114(5):347-60. PubMed ID: 18230059
[TBL] [Abstract][Full Text] [Related]
44. Genetic and Functional Characterization of Toll-Like Receptor Responses in Immunocompetent Patients With CMV Mononucleosis.
Frascaroli G; Rossini G; Maltoni V; Bartoletti M; Ortolani P; Gredmark-Russ S; Gelsomino F; Moroni A; Silenzi S; Castellani G; Sambri V; Mastroianni A; Brune W; Varani S
Front Cell Infect Microbiol; 2020; 10():386. PubMed ID: 32850485
[No Abstract] [Full Text] [Related]
45. Significance of P2X7 receptor variants to human health and disease.
Sluyter R; Stokes L
Recent Pat DNA Gene Seq; 2011 Apr; 5(1):41-54. PubMed ID: 21303345
[TBL] [Abstract][Full Text] [Related]
46. The effect of adenosine receptor agonists on cytokine release by human mononuclear cells depends on the specific Toll-like receptor subtype used for stimulation.
Ramakers BP; Riksen NP; Rongen GA; van der Hoeven JG; Smits P; Pickkers P
Cytokine; 2006 Jul; 35(1-2):95-9. PubMed ID: 16963274
[TBL] [Abstract][Full Text] [Related]
47. Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma.
Radstake TR; Roelofs MF; Jenniskens YM; Oppers-Walgreen B; van Riel PL; Barrera P; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Dec; 50(12):3856-65. PubMed ID: 15593217
[TBL] [Abstract][Full Text] [Related]
48. Immunomodulatory effects of polysaccharopeptide (PSP) in human PBMC through regulation of TRAF6/TLR immunosignal-transduction pathways.
Li W; Liu M; Lai S; Xu C; Lu F; Xiao X; Bao Y
Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):576-84. PubMed ID: 20131955
[TBL] [Abstract][Full Text] [Related]
49. Unique features of chicken Toll-like receptors.
Keestra AM; de Zoete MR; Bouwman LI; Vaezirad MM; van Putten JP
Dev Comp Immunol; 2013 Nov; 41(3):316-23. PubMed ID: 23628643
[TBL] [Abstract][Full Text] [Related]
50. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
[TBL] [Abstract][Full Text] [Related]
51. Innate immunity and adipocyte function: ligand-specific activation of multiple Toll-like receptors modulates cytokine, adipokine, and chemokine secretion in adipocytes.
Kopp A; Buechler C; Neumeier M; Weigert J; Aslanidis C; Schölmerich J; Schäffler A
Obesity (Silver Spring); 2009 Apr; 17(4):648-56. PubMed ID: 19148127
[TBL] [Abstract][Full Text] [Related]
52. Effect of peripheral blood mononuclear cell cryopreservation on innate and adaptive immune responses.
Anderson J; Toh ZQ; Reitsma A; Do LAH; Nathanielsz J; Licciardi PV
J Immunol Methods; 2019 Feb; 465():61-66. PubMed ID: 30447244
[TBL] [Abstract][Full Text] [Related]
53. Histamine Receptor 2 is Required to Suppress Innate Immune Responses to Bacterial Ligands in Patients with Inflammatory Bowel Disease.
Smolinska S; Groeger D; Perez NR; Schiavi E; Ferstl R; Frei R; Konieczna P; Akdis CA; Jutel M; OʼMahony L
Inflamm Bowel Dis; 2016 Jul; 22(7):1575-86. PubMed ID: 27271490
[TBL] [Abstract][Full Text] [Related]
54. Genetic polymorphisms in Toll-like receptors among pediatric patients with renal parenchymal infections of different clinical severities.
Cheng CH; Lee YS; Chang CJ; Lin TY
PLoS One; 2013; 8(3):e58687. PubMed ID: 23484049
[TBL] [Abstract][Full Text] [Related]
55. Histone lysine methyltransferase Ezh1 promotes TLR-triggered inflammatory cytokine production by suppressing Tollip.
Liu Y; Zhang Q; Ding Y; Li X; Zhao D; Zhao K; Guo Z; Cao X
J Immunol; 2015 Mar; 194(6):2838-46. PubMed ID: 25687760
[TBL] [Abstract][Full Text] [Related]
56. The ATP-P2X
Liu YH; Chang YC; Chen LK; Su PA; Ko WC; Tsai YS; Chen YH; Lai HC; Wu CY; Hung YP; Tsai PJ
Front Cell Infect Microbiol; 2018; 8():84. PubMed ID: 29616195
[No Abstract] [Full Text] [Related]
57. Stronger Toll-like receptor 1/2, 4, and 7/8 but less 9 responses in peripheral blood mononuclear cells in non-infectious exacerbated asthmatic children.
Lee WI; Yao TC; Yeh KW; Chen LC; Ou LS; Huang JL;
Immunobiology; 2013 Feb; 218(2):192-200. PubMed ID: 22727330
[TBL] [Abstract][Full Text] [Related]
58. P2X7 receptor-mediated leukocyte recruitment and Porphyromonas gingivalis clearance requires IL-1β production and autocrine IL-1 receptor activation.
Almeida-da-Silva CLC; Ramos-Junior ES; Morandini AC; Rocha GDC; Marinho Y; Tamura AS; de Andrade KQ; Bellio M; Savio LEB; Scharfstein J; Ojcius DM; Coutinho-Silva R
Immunobiology; 2019 Jan; 224(1):50-59. PubMed ID: 30429052
[TBL] [Abstract][Full Text] [Related]
59. Toll-like receptor 2 and 4 induced interleukin-19 dampens immune reactions and associates inversely with spondyloarthritis disease activity.
Kragstrup TW; Andersen T; Holm C; Schiøttz-Christensen B; Jurik AG; Hvid M; Deleuran B
Clin Exp Immunol; 2015 May; 180(2):233-42. PubMed ID: 25639337
[TBL] [Abstract][Full Text] [Related]
60. Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells.
Mäkelä SM; Strengell M; Pietilä TE; Osterlund P; Julkunen I
J Leukoc Biol; 2009 Apr; 85(4):664-72. PubMed ID: 19164128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
